Testing effectiveness (Phase 2)UnknownNCT02075086What this trial is testingAngiogenic Switch in Patients With Colorectal CancerWho this might be right forColorectal Cancer Grupo Hospital de Madrid 100
Testing effectiveness (Phase 2)Ended earlyNCT00251186What this trial is testingFirst-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly PatientsWho this might be right forColorectal Cancer University of Medicine and Dentistry of New Jersey 18
Testing effectiveness (Phase 2)Study completedNCT00215995What this trial is testingCisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric CarcinomasWho this might be right forEsophageal CancerGastric Cancer H. Lee Moffitt Cancer Center and Research Institute 21
Early research (Phase 1)Looking for participantsNCT07114601What this trial is testingLY4257496 in Participants With Cancer (OMNIRAY)Who this might be right forBreast NeoplasmsColorectal NeoplasmsProstate Neoplasm+4 more Eli Lilly and Company 421
Early research (Phase 1)Looking for participantsNCT07189195What this trial is testingTR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic AdenocarcinomaWho this might be right forAdvanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmMetastatic Pancreatic Adenocarcinoma+5 more University of California, Davis 52
Testing effectiveness (Phase 2)Study completedNCT00048139What this trial is testingXeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal CancerWho this might be right forColorectal Cancer Hoffmann-La Roche 52
Large-scale testing (Phase 3)Ended earlyNCT01767857What this trial is testingA Phase III Study of Xilonix in Patients With Advanced Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Janssen Research & Development, LLC 643
Testing effectiveness (Phase 2)UnknownNCT00024375What this trial is testingDHA-Paclitaxel in Treating Patients With Metastatic Pancreatic CancerWho this might be right forPancreatic Cancer Theradex
Large-scale testing (Phase 3)Active Not RecruitingNCT03428477What this trial is testingEPA for Metastasis Trial 2Who this might be right forLiver MetastasisColon Cancer Mark A Hull, PhD FRCP 418
Not applicableUnknownNCT03156777What this trial is testingApplication Value of CTCs Detection for Advanced Gastric Cancer PatientsWho this might be right forCirculating Tumor CellsGastric Cancer Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 200
Not applicableStudy completedNCT07409987What this trial is testingTENS and Compression for Established Oxaliplatin-Induced Peripheral NeuropathyWho this might be right forCIPN - Chemotherapy-Induced Peripheral NeuropathyGastrointestinal Cancers Cumhuriyet University 140
Early research (Phase 1)Temporarily pausedNCT05958199What this trial is testingNPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7Who this might be right forMetastatic Malignant Neoplasm NextPoint Therapeutics, Inc. 131
Testing effectiveness (Phase 2)Active Not RecruitingNCT04396821What this trial is testingA Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid TumorsWho this might be right forAdvanced CancerGastric CancerGastroesophageal-junction Cancer+1 more Transcenta Therapeutics (Hangzhou) Co., Ltd. 150
Early research (Phase 1)Study completedNCT01198821What this trial is testingGem-TABS in Unresectable Pancreatic CarcinomaWho this might be right forPancreatic Cancer H. Lee Moffitt Cancer Center and Research Institute 8
Testing effectiveness (Phase 2)Study completedNCT05864144What this trial is testingSNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid TumorsWho this might be right forSolid Tumor, AdultAdvanced Solid TumorHead and Neck Cancer+19 more Sensei Biotherapeutics, Inc. 98
Early research (Phase 1)Study completedNCT00844064What this trial is testingSafety and Tolerability of AP 12009, Administered I.V. in Patients With Advanced Tumors Known to Overproduce TGF-beta-2Who this might be right forPancreatic NeoplasmsMelanomaColorectal Neoplasms Isarna Therapeutics GmbH 62
Testing effectiveness (Phase 2)UnknownNCT03668431What this trial is testingDabrafenib + Trametinib + PDR001 In Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Massachusetts General Hospital 25
Testing effectiveness (Phase 2)Study completedNCT05025631What this trial is testingA Phase II Study on Dose Optimization of Fruquintinib in Elderly mCRC Patients Refractory to Standard Treatment（DOFEMCRC）Who this might be right forColorectal Cancer Zhen-Yu Ding 29
Not applicableStudy completedNCT03446872What this trial is testingPost Marketing Surveillance Study for ONIVYDE® in South KoreaWho this might be right forMetastatic Pancreatic Cancer Institut de Recherches Internationales Servier 94
Testing effectiveness (Phase 2)Looking for participantsNCT03412877What this trial is testingAdministration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic CancerWho this might be right forEndocrine TumorsNon-Small Cell Lung CancerOvarian Cancer+4 more National Cancer Institute (NCI) 285